NASDAQ · Financial Statements

LifeStance Health Group, Inc. (LFST) Revenue, Earnings & Financial Statements

$14.17 NASDAQ: LFST Market Cap $5.39B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

LifeStance Health Group, Inc. most recently reported annual revenue of $1.4B, net profit of $10.0M. Revenue grew at an average annual rate of 30.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

LifeStance Health Group, Inc.: Revenue rose from $213.0M in 2019 to $1.4B in 2025, a change of +568.5% over 6 years; net profit was positive in 2 of 7 reported years; operating margin moved from 7.2% to 1.7%, a shift of -5.5 percentage points; the most recent year shows net profit of $10.0M.

Income Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Revenue$213.0M$377.0M$668.0M$860.0M$1.1B$1.3B$1.4B
Operating Expenses$197.0M$362.0M$954.0M$1.1B$1.2B$1.3B$1.4B
Operating Profit$15.0M$15.0M−$286.0M−$210.0M−$189.0M−$32.0M$24.0M
Operating Margin7.2%4.1%-42.9%-24.4%-17.9%-2.5%1.7%
Other Income−$7.0M−$60.0M−$47.0M−$23.0M−$17.0M−$26.0M−$12.0M
Interest$5.0M$22.0M$39.0M$20.0M$21.0M$27.0M$12.0M
Depreciation$6.0M$31.0M$54.0M$69.0M$80.0M$71.0M$55.0M
Profit Before Tax$8.0M−$44.0M−$333.0M−$233.0M−$207.0M−$58.0M$12.0M
Tax rate (%)28.0%14.3%7.8%7.4%9.8%0.3%21.8%
Net Profit$6.0M−$38.0M−$307.0M−$216.0M−$186.0M−$57.0M$10.0M
EPS−$0.16−$0.83−$1.05−$0.61−$0.51−$0.15$0.02

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$281.0M$300.0M$312.0M$313.0M$325.0M$333.0M$345.0M$364.0M$382.0M$403.0M$435.0M$456.0M
Operating Expenses$313.0M$317.0M$328.0M$313.0M$324.0M$331.0M$348.0M$356.0M$364.0M$381.0M$405.0M$423.0M
Operating Profit−$32.0M−$17.0M−$16.0M$0$1.0M$2.0M−$3.0M$7.0M$18.0M$22.0M$31.0M$33.0M
Operating Margin-11.5%-5.6%-5.1%0.0%0.3%0.5%-0.8%2.0%4.7%5.5%7.0%7.3%
Interest$6.0M$6.0M$6.0M$5.0M$9.0M$3.0M$3.0M$3.0M$3.0M$2.0M$3.0M$2.0M
Profit Before Tax−$38.0M−$21.0M−$23.0M−$5.0M−$9.0M−$1.0M−$6.0M$5.0M$15.0M$20.0M$27.0M$27.0M
Tax rate (%)-17.3%-1.8%-2.9%-10.7%19.9%148.2%36.2%76.4%23.3%27.9%14.0%18.3%
Net Profit−$45.0M−$21.0M−$23.0M−$6.0M−$7.0M$1.0M−$4.0M$1.0M$12.0M$14.0M$24.0M$22.0M
EPS−$0.12−$0.06−$0.06−$0.02−$0.02$0.00−$0.01$0.00$0.03$0.04$0.06$0.06

Over the 7 years reported for LifeStance Health Group, Inc., borrowings increased from $79.0M in 2019 to $194.0M in 2025, cash stood at $249.0M in the latest year, shareholders' equity was $4.0M, current assets covered current liabilities 1.65 times.

Balance Sheet — 7 Years (USD millions)

Metric2019202020212022202320242025
Total Assets$281.0M$1.6B$1.9B$2.2B$2.1B$2.1B$2.2B
Current Assets$27.0M$76.0M$267.0M$233.0M$226.0M$313.0M$416.0M
Cash$3.0M$19.0M$148.0M$109.0M$79.0M$155.0M$249.0M
Inventory$0$0$38.0M$0$0$0$0
Receivables$19.0M$44.0M$99.0M$102.0M$126.0M$132.0M$96.0M
Fixed Assets$22.0M$59.0M$152.0M$394.0M$359.0M$314.0M$311.0M
Capital Work in Progress$0$0$0$0$0$0$0
Investments$0−$11.0M−$43.0M$0$0$0$0
Other Assets$215.0M$1.1B$1.2B$1.3B$1.3B$1.3B$1.3B
Total Liabilities$447.0M$572.0M$382.0M$655.0M$681.0M$672.0M$683.0M
Current Liabilities$55.0M$76.0M$117.0M$176.0M$203.0M$229.0M$252.0M
Borrowings$79.0M$366.0M$159.0M$479.0M$511.0M$485.0M$194.0M
Other Liabilities$368.0M$206.0M$223.0M$176.0M$170.0M$187.0M$489.0M
Equity$0$1.0B$4.0M$4.0M$4.0M$4.0M$4.0M
Reserves−$166.0M$998.0M$1.5B$1.5B$1.4B$1.4B$1.5B

For LifeStance Health Group, Inc., operating cash flow was positive in 5 of 7 reported years; free cash flow in the latest year was $110.0M; free cash flow was positive in 3 of 7 years; financing activities used $9.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Operating Cash Flow$17.0M−$9.0M$9.0M$53.0M−$17.0M$107.0M$146.0M
Investing Cash Flow−$88.0M−$899.0M−$289.0M−$219.0M−$101.0M−$43.0M−$72.0M
Financing Cash Flow−$7.0M$600.0M−$12.0M−$22.0M−$8.0M−$8.0M−$9.0M
Net Cash Flow−$8.0M$15.0M$129.0M−$39.0M−$30.0M$76.0M$94.0M
Free Cash Flow$3.0M−$47.0M−$85.0M−$26.0M−$57.0M$86.0M$110.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA36.68
FCF Yield3.28%
Quick Ratio1.44
Interest Coverage10.63
Return 1Y123.14%
Return 3Y126.73%
Return 5Y38.97%

LifeStance Health Group, Inc. (LFST) financials — frequently asked questions

What is LifeStance Health Group, Inc.'s annual revenue?

LifeStance Health Group, Inc. (LFST) reported annual revenue of $1.4B in its most recent fiscal year.

What is LifeStance Health Group, Inc.'s net profit?

LifeStance Health Group, Inc. (LFST) reported net profit of $10.0M in its most recent fiscal year.

What is LFST EV/EBITDA?

LifeStance Health Group, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 36.68.

Revenue and earnings of other Medical - Care Facilities stocks

HCA revenue $75.6BTHC revenue $21.3BEHC revenue $5.9BDVA revenue $13.6BENSG revenue $5.1BUHS revenue $17.4BCHE revenue $2.5BOPCH revenue $5.7BHIMS revenue $2.3BACHC revenue $3.3BAll Medical - Care Facilities stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
LFST Overview LFST Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.